Karen Knudsen, MBA PhD, Appointed Chief Executive Officer of the Parker Institute for Cancer Immunotherapy

The Parker Institute for Cancer Immunotherapy (PICI) today announced the appointment of Karen E. Knudsen, MBA PhD as its new chief executive officer. A visionary leader in oncology, healthcare delivery, scientific innovation, and strategic transformation, Dr. Knudsen joins PICI at a pivotal time, and brings significant expertise in converting scientific discoveries into real world benefit for cancer patients.

"For nearly a decade, PICI has been at the forefront of transforming cancer treatment through the power of immunotherapy—reshaping what is possible in the fight against this disease. But there is more to be done, particularly at this critical time. I believe the institute's bold, unique model and long-term commitment to catalyzing innovations into clinical testing and near-term patient benefits are exactly the type of support needed to drive continued progress against cancer. This is all the more critical despite the current funding climate," said Knudsen. "I am honored to lead this extraordinary team of scientists, research institutions, and industry leaders as we push the boundaries and speed of innovation even further. Together, we will accelerate the development of life-saving therapies, expand the reach of PICI's impact, and bring the vision of turning all cancers into curable diseases to reality."